IMMUNITRACK is founded upon world-leading academic research on MHC-epitope binding. Using our deep knowledge in this area, we have developed the proprietary epitope screening platform technology, NeoScreen®. NeoScreen® accurately assays the affinity and stability of MHC/epitope interactions, and the technology has the capacity to rapidly screen libraries with thousands of (neo-)epitopes for applications within immune-oncology, vaccine production, T cell therapies and immune monitoring.

IMMUNITRACK’s mission is to provide the pharmaceutical industry and research community with technology and reagents to select or redesign drug candidates during early R&D and to monitor the effects of lead drug candidates on patient immune responses. Besides being a service provider, we are also a world-leading manufacturer and supplier of MHC tetramers.

IMMUNITRACK actively collaborates with some of the leading research groups within immuno-oncology  as well as leading pharmaceutical and biotech companies.

Contact name:

Stephan Thorgrimsen


Lersø Parkallée 42, 2100 Copenhagen Ø, Denmark

If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact or +45 5150 0560

Copyright 2015 Danskbiotek. All rights reserved.